참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | L-Isoleucine | HCID 6306 | — |
| 반응물 | ThzLeu | HCID 39259773 | — |
| 반응물 | IleThz | HCID 61161360 | — |
| 반응물 | IleThzLeu | HCID 131730359 | — |
| 반응물 | IleThzLeuGlu | HCID 131730360 | — |
| 반응물 | ThzLeuGlu | HCID 131730361 | — |
| 반응물 | HCID 178455890 | HCID 178455890 | — |
| 생성물 | Bacitracin | HCID 10909430 | — |
반응 단계
Using the same methodology as for Bacitracin A, the location of a modification responsible for the +12 Da difference from Bacitracin A, could be determined. The doubly protonated molecular ion ([M+2H]2+, m/z 718.0) was isolated and fragmented and the resulting product ion (MS/MS) spectrum is shown in FIG. 4B. The spectrum contains a full set of y″ ions with m/z 1349.7/675.82+ (loss of Ile), m/z 1236.7/619.12+ (loss of IleThz), m/z 1123.7 (loss of IleThzLeu), m/z 994.6/498.12+ (loss of IleThzLeuGlu) and m/z 869.6 (loss of IleThzLeuGluMil). These fragment assignments are visualized in FIG. 4A. In addition to the b ions with m/z 566.4 (IleThzLeuGluMil) and m/z 441.3 (IleThzLeuGlu), fragment ions resulting from pairs of bond cleavages can be seen at m/z 227.1 (ThzLeu), m/z 356.1 (ThzLeuGlu) and at m/z 481.2 (ThzLeuGluMil).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08410044B2 |
|---|
| 출처 데이터셋 | uspto-grants-2013_04 |
|---|
| ORD ID | ord-b82d39e898fa4193a3760eeecd1ca608 |
|---|
| 출처 메모 | uspto-grants-2013_04 |
|---|